Terri Pustilnik, MD
Gynecologic Oncology · Webster, TXNPI 1669457321
Payments from drug & device makers
Across 120 payments — averaging $808.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$62K
- Intuitive Surgical$25K
- Virtual Incision Corporation$6K
- Johnson & Johnson$2K
- GSK$419
- Baxter Healthcare$282
- plus $2K from 19 others
What the payments were for
- Consulting fees$6,2256%
- Speaking & faculty fees$54,35056%
- Travel & lodging$6,6177%
- Food & beverage$5,4036%
- Education$24,00025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 56 | $61,730 |
| Intuitive Surgical | 12 | $24,900 |
| Virtual Incision Corporation | 2 | $6,164 |
| Johnson & Johnson(2 entities) | 11 | $1,616 |
| GSK | 10 | $419 |
| Baxter Healthcare | 2 | $282 |
| Coopersurgical, Inc. | 1 | $225 |
| Edwards Lifesciences | 1 | $189 |
| Medical Device Business Services, Inc. | 4 | $181 |
| Davol Inc. | 1 | $162 |
| Integra Lifesciences Corporation | 1 | $145 |
| Pacira Pharmaceuticals Incorporated | 2 | $140 |
| Karyopharm Therapeutics Inc. | 1 | $139 |
| Tesaro, Inc. | 1 | $125 |
| G1 Therapeutics, Inc. | 1 | $94 |
| Stryker | 1 | $93 |
| Myriad Genetic Laboratories, Inc. | 1 | $83 |
| Acessa Health Inc. | 1 | $81 |
| Novartis | 3 | $67 |
| Merck | 2 | $60 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Amgen | 1 | $32 |
| Incyte Corporation | 1 | $24 |
| Sobi, Inc | 1 | $22 |
| Bayer | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$60,464
- Da Vinci Surgical System$24,900
- Mira!$6,164
- TISSEEL$282
- ZEJULA$247
- Uterine Manipulators & Injectors$225
- HemoSphere$189
- ARISTA AH FLEXITIP$162
- Enseal X1$146
- CODMAN CERTAS$145
- CUSA CLARITY$145
- CODMAN HAKIM$145
- DURASEAL EXACT SPINAL SEALANT SYSTEM$145
- Enseal$142
- XPOVIO$139
- EXPAREL$124
- Echelon Flex$116
How this compares
$97,048 in reported general payments places this provider in the 75th percentile of 135 gynecologic oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $131 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Webster
- Pamela SolimanHouston$30.7M
- Noelle ClovenFort Worth$7.3M
- Christine LeeShenandoah$6.3M
- Antonio Santillan-GomezSan Antonio$4.5M
- Jayanthi LeaDallas$3.9M
- Helen EshedAustin$3.5M
- Robert ColemanHouston$3.4M
- Michael TenerielloAustin$2.9M
- Heather PulaskiTyler$2.5M
- David MillerDallas$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.